Dose 2 gevokizumab

DRUG3 trials

Sponsors

XOMA (US) LLC

Conditions

Uveitis

Phase 3

Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis

TerminatedNCT01684345

XOMA (US) LLCUveitis

Start: 2012-08-31Updated: 2016-04-08

Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment

TerminatedNCT01747538

XOMA (US) LLCUveitis

Start: 2012-10-31Updated: 2016-07-12

An Open-label, Rollover Study Providing Continued Dosing of Gevokizumab in Order to Assess Long-term Gevokizumab Safety Data

TerminatedNCT02258854

XOMA (US) LLCUveitis

Start: 2014-03-31End: 2017-12-31Updated: 2015-10-16